Release Date: January 2013
Expiration Date: January 2014
Continue Reading
Estimated time to complete the educational activity: 1 hour
This activity is jointly sponsored by Medical Education Resources and Haymarket Medical Education.
Statement of Need: In the vast majority of patients with renal cell carcinoma (RCC), extensive nephropathological findings are observed in the non-neoplastic kidney at the time of nephrectomy. At present, it is unknown if these nephropathological changes somehow induce renal neoplasia or are simply the result of medical comorbidities that are prevalent in kidney tumor patients. Thus, a working knowledge of the relationship between chronic kidney disease and RCC is now essential for all urologic oncologists.
Target Audience: This activity has been designed to meet the educational needs of urologists, -urologic oncologists, and allied healthcare clinicians who treat patients for chronic kidney disease, particularly end-stage renal disease, and associated cancer.
Educational Objectives: After completing the activity, the participant should be better able to:
- Review recent literature that identifies the association between end-stage renal disease and malignancy
- Discuss kidney cancer-associated nephropathology and the surgical management of renal tumors
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Medical Education. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest: Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity
| Name of Faculty | Reported Financial Relationship |
| Paul Russo, MD | Consulting Fees: Wilex AG |
The content managers, Jody A. Charnow and Marina Galanakis, of Haymarket Medical Education, and Julie Johnson, PharmD, of Medical Education Resources, have disclosed that they have no relevant financial relationships or conflicts of interest.
Method of Participation: There are no fees for participating in and receiving CME credit for this activity. During the period December 2012 through December 2013, participants must: 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest and submit it online. Physicians may register at www.myCME.com/renalandurologynews, and 4) complete the evaluation form online.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.
